Viemed Healthcare, Inc. (VMD) stock
VMDNasdaqServices-Misc Health & Allied Services, NECFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 17/3016% below fair value
$9.07−0.08 (-0.87%)
Close on Nov 17, 2026Market cap $345.46MP/E 25.2Yield –
Viemed Healthcare operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Viemed Healthcare's operating cash flow for the twelve months ending Jun 30, 2026 was $60.78M, up 41.9% year over year. For fiscal 2025 it was $51.92M, up 32.8% from the year before. The highest annual figure on record is $51.92M in fiscal 2025.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $51.92M | +32.8% |
| FY2024 | Dec 31, 2024 | $39.09M | -13.5% |
| FY2023 | Dec 31, 2023 | $45.21M | +62.9% |
| FY2022 | Dec 31, 2022 | $27.75M | +23.4% |
| FY2021 | Dec 31, 2021 | $22.49M | -35.9% |
| FY2020 | Dec 31, 2020 | $35.11M | +83.9% |
| FY2019 | Dec 31, 2019 | $19.09M | -14.7% |
| FY2018 | Dec 31, 2018 | $22.37M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $15.90M | +29.8% |
| Q1 FY2026 | Mar 31, 2026 | $8.07M | +182.8% |
| Q4 FY2025 | Dec 31, 2025 | $18.44M | +23.0% |
| Q3 FY2025 | Sep 30, 2025 | $18.37M | +44.1% |
| Q2 FY2025 | Jun 30, 2025 | $12.25M | +20.3% |
| Q1 FY2025 | Mar 31, 2025 | $2.85M | +142.9% |
| Q4 FY2024 | Dec 31, 2024 | $14.99M | +12.8% |
| Q3 FY2024 | Sep 30, 2024 | $12.75M | -7.7% |
| Q2 FY2024 | Jun 30, 2024 | $10.18M | +33.6% |
| Q1 FY2024 | Mar 31, 2024 | $1.18M | -88.8% |
| Q4 FY2023 | Dec 31, 2023 | $13.28M | +72.9% |
| Q3 FY2023 | Sep 30, 2023 | $13.81M | +73.2% |
| Q2 FY2023 | Jun 30, 2023 | $7.62M | +54.1% |
| Q1 FY2023 | Mar 31, 2023 | $10.50M | +46.9% |
| Q4 FY2022 | Dec 31, 2022 | $7.68M | -11.2% |
| Q3 FY2022 | Sep 30, 2022 | $7.97M | +58.6% |
| Q2 FY2022 | Jun 30, 2022 | $4.95M | +18.2% |
| Q1 FY2022 | Mar 31, 2022 | $7.15M | +54.4% |
| Q4 FY2021 | Dec 31, 2021 | $8.66M | +49.5% |
| Q3 FY2021 | Sep 30, 2021 | $5.03M | -31.4% |
| Q2 FY2021 | Jun 30, 2021 | $4.18M | -80.4% |
| Q1 FY2021 | Mar 31, 2021 | $4.63M | +662.4% |
| Q4 FY2020 | Dec 31, 2020 | $5.79M | -21.7% |
| Q3 FY2020 | Sep 30, 2020 | $7.33M | +28.1% |
| Q2 FY2020 | Jun 30, 2020 | $21.38M | +302.4% |
| Q1 FY2020 | Mar 31, 2020 | $607.00K | -6.6% |
| Q4 FY2019 | Dec 31, 2019 | $7.40M | -9.8% |
| Q3 FY2019 | Sep 30, 2019 | $5.72M | +11.0% |
| Q2 FY2019 | Jun 30, 2019 | $5.31M | – |
| Q1 FY2019 | Mar 31, 2019 | $650.00K | – |
| Q4 FY2018 | Dec 31, 2018 | $8.21M | – |
| Q3 FY2018 | Sep 30, 2018 | $5.16M | – |
See a number that looks wrong?